Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes. - Wikidata - awgldk - TriplyDB

Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.

Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.

http://www.wikidata.org/entity/Q34944244

about

Large numbers of individuals are required to classify and define risk for rare variants in known cancer risk genes Implementation and outcomes of telephone disclosure of clinical BRCA1/2 test results.Development of a communication protocol for telephone disclosure of genetic test results for cancer predisposition Women's concerns about the emotional impact of awareness of heritable breast cancer risk and its implications for their children.Calibration of multiple in silico tools for predicting pathogenicity of mismatch repair gene missense substitutions.Long-term psychosocial outcomes of BRCA1/BRCA2 testing: differences across affected status and risk-reducing surgery choice.Genetic counselors' practices and confidence regarding variant of uncertain significance results and reclassification from BRCA testing.Variants of unknown significance on chromosomal microarray analysis: parental perspectives.Psychosocial and Quality of Life in Women Receiving the 21-Gene Recurrence Score Assay: The Impact of Decision Style in Women with Intermediate RS.Cognitive and emotional factors predicting decisional conflict among high-risk breast cancer survivors who receive uninformative BRCA1/2 results Bridging the Communication Divide: A Role for Health Psychology in the Genomic Era.Short-term psychological impact of the BRCA1/2 test result in women with breast cancer according to their perceived probability of genetic predisposition to cancer Understanding the Needs of Young Women Regarding Breast Cancer Risk Assessment and Genetic Testing: Convergence and Divergence among Patient-Counselor Perceptions and the Promise of Peer Support.Genetics: breast cancer as an exemplar Family Studies for Classification of Variants of Uncertain Classification: Current Laboratory Clinical Practice and a New Web-Based Educational Tool.Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.Psychiatric implications of cancer genetic testing.Patient reported outcomes and patient empowerment in clinical genetics services.Attitudes, knowledge and consequences of uncertain genetic findings in hypertrophic cardiomyopathy.Evaluation of laboratory perspectives on hereditary cancer panels.A web-based personalized risk communication and decision-making tool for women with dense breasts: Design and methods of a randomized controlled trial within an integrated health care system.Newborn Screening for Lysosomal Storage Disorders: Views of Genetic Healthcare Providers.Precision reproductive medicine: multigene panel testing for infertility risk assessment.Classifying variants of CDKN2A using computational and laboratory studies.Modeling the dyadic effects of parenting, stress, and coping on parent-child communication in families tested for hereditary breast-ovarian cancer risk.A follow-up study on men tested for BRCA1/BRCA2 mutations: impacts and coping processes.Psychological distress related to BRCA testing in ovarian cancer patients.Examining the Psychosocial Impact of Genetic Testing for Cardiomyopathies.From the laboratory to the clinic: sharing BRCA VUS reclassification tools with practicing genetics professionals.Clinical Variant Classification: A Comparison of Public Databases and a Commercial Testing Laboratory.Follow-up of carriers of BRCA1 and BRCA2 variants of unknown significance: variant reclassification and surgical decisions.Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients.

P2860

Q33779382-26EA7AD9-1806-439A-AAFD-9C54B9A9E305 Q34351357-E8D0D32D-8A3B-4B2E-802F-AF88208C66D2 Q34657518-B92F3CDC-834A-4468-986E-7B30BDE7CB4F Q34862339-AD47BFD3-3A69-4942-B8B9-7F832C0321E9 Q35053897-C6EE14F2-AFDA-4F07-97F6-8BEA46378876 Q35815469-9A6F840D-9E66-4A5F-A70A-79D1CA8D2931 Q35909002-F9F4125E-876C-4A5C-ACD9-1D7F19D4B6BF Q36054612-55ABCFD0-16DD-439A-98F7-FDA2EE160BD2 Q36147839-F48C7DB9-B6B1-4A41-9024-84F477AFB87F Q36433719-544D9712-270D-451F-9000-9223C7A635EF Q36678417-7543C1F6-1476-475D-AEE9-5AF1D1C69BDB Q36746707-1FAFAE47-BDD1-4101-AA2E-B2092FE7703D Q37293888-E6618482-CAD4-4F54-913E-308186E0546E Q37357662-37614559-BD41-4120-BB22-6DFB0737889A Q37421265-0F5D22EC-44AF-4DB0-831B-749D5EAF4F22 Q37602222-F5FAA364-21AF-4832-B964-983FAECAF8C2 Q38252441-BAD28E7A-0697-42FF-BBA1-784D544BAAB3 Q38259348-4B6BE25C-1CD9-4E1B-B900-97CF9C1B42EE Q38736582-B26A49D5-6318-41BC-B0B8-A0B1A65F37B8 Q38909157-867250B6-C7FA-4629-A806-B3452FEEB869 Q38930672-4421F483-39DC-46C9-9D2A-F29D5EDDA128 Q38969789-407D4096-4B8E-4220-9B5E-16D5CE7949F9 Q39282504-43861AA7-9EBB-48EF-B6AB-C46D98F79AF2 Q39564985-676B054F-E4EB-4DAC-A142-09AF6C3DAC06 Q40020744-61562258-3AF8-4F03-A322-38DC40F18DE1 Q44507838-1143D41D-D67B-42C8-BC01-3F6AEA2C8E1E Q47698893-3DD2E55D-63F6-49AB-82A5-28AA2DAF1345 Q48113845-323AD101-DBEC-4D1A-944F-D8FC464E578D Q48328498-5CAB9581-0406-4740-99A8-D2232BE896D5 Q50728624-349E6370-85AD-44A5-BF95-7B8AC3C3B3EB Q51017508-AFC2FA25-5A47-4FB2-85BB-3F0A74F64EAD Q53392165-4E004E80-397D-49BE-BF9F-A64AD3BEEC1A

P2860

Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.

http://www.wikidata.org/entity/Q34944244

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.

@ast

Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.

@en

Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.

@nl

type

label

Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.

@ast

Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.

@en

Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.

@nl

prefLabel

Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.

@ast

Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.

@en

Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.

@nl

P1433

Q34944244-5166C15D-1763-4C6D-BFDA-5A982E7A7236

P1476

Q34944244-D5E66047-B122-42F3-A419-E23B8DA20E56

P2093

Q34944244-0AA25CBC-2EF7-41A8-97FA-B9D6C557B1CA

Q34944244-64D5657E-08E5-408D-825C-EFBD27EEA84D

Q34944244-7C820E75-ADE4-4A02-BE44-2D5B762B8D88

Q34944244-AC1EB987-8DBB-4B4B-ABE0-EEDEBCC881A3

Q34944244-B3C30389-F746-459B-A317-F9D08682ADA1

Q34944244-DE85E23B-7E8B-445A-8E25-C34DA4C21169

P2860

Q34944244-025BEAE3-F403-40A0-BD67-81111886D2ED

Q34944244-0DE119E3-5450-47D8-B80D-A61988267D72

Q34944244-1B6D6FAD-3338-4510-97CF-EE1CF3B76DA6

Q34944244-2B4D5D54-E390-4855-BC14-21521275A116

Q34944244-2C8DEFCF-C759-4FC6-9451-FC9B9E479867

Q34944244-3F34694C-13E2-4941-8168-61FDD2407270

Q34944244-4846954A-73DA-4870-BF5B-D8FC4DDD3A70

Q34944244-49085DFD-54E8-4FF1-83BC-5F9A5DB44353

Q34944244-4F4E1D0D-82CD-4EDD-A2E8-21CF87A2ECCA

Q34944244-613A6AF3-4BE3-4D06-907F-77E684EC9F7E

P304

Q34944244-00B8A3FC-0DB5-4205-A641-5AE1D5729F58

P31

Q34944244-EAB7A151-9FB0-4E29-AFC6-D4AFF6704836

P356

Q34944244-5E49450C-53E3-4B83-8FEB-004729935CC0

P433

Q34944244-41FED2D9-A28A-4A3A-8A8E-5D3C49D0FA46

P478

Q34944244-28997344-38A8-45CA-AED1-89ACD66E8145

P577

Q34944244-8B161F21-8625-48EA-B379-8B7CF8FFD463

P5875

Q34944244-F3DC69AC-2799-49F4-B516-C369B9E37866

P698

Q34944244-142142D1-85EE-4F5D-9339-966A55873C20

P932

Q34944244-0ED0793E-6A9E-4473-8264-6C418F123B6E

P356

P1433

Psycho-Oncology

P1476

Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.

@en

P2093

Christine Rini

http://www.w3.org/2001/XMLSchema#string

Heiddis Valdimarsdottir

http://www.w3.org/2001/XMLSchema#string

Lawrence H Cohen

http://www.w3.org/2001/XMLSchema#string

Marc D Schwartz

http://www.w3.org/2001/XMLSchema#string

Rachel E Goldsmith

http://www.w3.org/2001/XMLSchema#string

Suzanne C O'Neill

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis of BRCA1 and BRCA2 penetrance

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.

Breast cancer genetics: what we know and what we need.

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.

Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.

Cancer risks in BRCA2 mutation carriers.

The anchoring-and-adjustment heuristic: why the adjustments are insufficient.

Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors

Decision making and decision support for hereditary breast-ovarian cancer susceptibility.

Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.

P304

1088-1096

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PON.1467

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24005978

http://www.w3.org/2001/XMLSchema#string

P698

19214961

http://www.w3.org/2001/XMLSchema#string

P932

3503506

http://www.w3.org/2001/XMLSchema#string